Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Comparison of the effects of twice-daily exenatide and insulin on carotid intima-media thickness in type 2 diabetes mellitus patients: a 52-week randomized, open-label, controlled trial
Authors
Keywords
-
Journal
Cardiovascular Diabetology
Volume 19, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-04-25
DOI
10.1186/s12933-020-01014-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Once-Weekly Exenatide on Clinical Outcomes in Patients With Preexisting Cardiovascular Disease
- (2019) Robert J. Mentz et al. CIRCULATION
- Exenatide once-weekly improves metabolic parameters, endothelial dysfunction and carotid intima-media thickness in patients with type-2 diabetes: An 8-month prospective study
- (2019) Angelo Maria Patti et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Exenatide twice-daily does not affect renal function or albuminuria compared to titrated insulin glargine in patients with type 2 diabetes mellitus: a post-hoc analysis of a 52-week randomised trial
- (2019) M.H.A. Muskiet et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Atherosclerotic cardiovascular disease and heart failure: Determinants of risk and outcomes in patients with diabetes
- (2019) Adam J. Nelson et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Risk of heart failure hospitalization among users of dipeptidyl peptidase-4 inhibitors compared to glucagon-like peptide-1 receptor agonists
- (2018) Ghadeer K. Dawwas et al. Cardiovascular Diabetology
- Mechanisms of Action and Therapeutic Application of Glucagon-like Peptide-1
- (2018) Daniel J. Drucker Cell Metabolism
- Impact of intravenous exenatide infusion for perioperative blood glucose control on myocardial ischemia-reperfusion injuries after coronary artery bypass graft surgery: sub study of the phase II/III ExSTRESS randomized trial
- (2018) Guillaume Besch et al. Cardiovascular Diabetology
- Cholesterol transport system: An integrated cholesterol transport model involved in atherosclerosis
- (2018) Xiao-Hua Yu et al. PROGRESS IN LIPID RESEARCH
- Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
- (2017) Rury R. Holman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Insulin Therapy Increases Cardiovascular Risk in Type 2 Diabetes
- (2017) Mary E. Herman et al. PROGRESS IN CARDIOVASCULAR DISEASES
- Effectiveness and safety of exenatide in Korean patients with type 2 diabetes inadequately controlled with oral hypoglycemic agents: an observational study in a real clinical practice
- (2017) You-Cheol Hwang et al. BMC Endocrine Disorders
- Serum total cholesterol and risk of cardiovascular and non-cardiovascular mortality in old age: a population-based study
- (2017) Yajun Liang et al. BMC Geriatrics
- Liraglutide improves metabolic parameters and carotid intima-media thickness in diabetic patients with the metabolic syndrome: an 18-month prospective study
- (2016) Manfredi Rizzo et al. Cardiovascular Diabetology
- Presentations of major peripheral arterial disease and risk of major outcomes in patients with type 2 diabetes: results from the ADVANCE-ON study
- (2016) Kamel Mohammedi et al. Cardiovascular Diabetology
- Carotid Intima-Media Thickness for Atherosclerosis
- (2016) Tomohisa Nezu et al. Journal of Atherosclerosis and Thrombosis
- The Use of Exenatide in Managing Markers of Cardiovascular Risk in Patients with Type 2 Diabetes: A Systematic Review
- (2016) Omorogieva Ojo International Journal of Environmental Research and Public Health
- Long-term changes in cardiovascular risk markers during administration of exenatide twice daily or glimepiride: results from the European exenatide study
- (2015) Rafael Simó et al. Cardiovascular Diabetology
- Profile of the Immune and Inflammatory Response in Individuals With Prediabetes and Type 2 Diabetes
- (2015) Vera Grossmann et al. DIABETES CARE
- Liraglutide decreases carotid intima-media thickness in patients with type 2 diabetes: 8-month prospective pilot study
- (2014) Manfredi Rizzo et al. Cardiovascular Diabetology
- Exenatide Twice Daily: A Review of Its Use in the Management of Patients with Type 2 Diabetes Mellitus
- (2014) Paul L. McCormack DRUGS
- Decreased carotid atherosclerotic process by control of daily acute glucose fluctuations in diabetic patients treated by DPP-IV inhibitors
- (2013) M. Barbieri et al. ATHEROSCLEROSIS
- Diagnosis and Classification of Diabetes Mellitus
- (2013) DIABETES CARE
- Exenatide improves endothelial function assessed by flow mediated dilation technique in subjects with type 2 diabetes: Results from an observational research
- (2012) Concetta Irace et al. Diabetes & Vascular Disease Research
- GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus
- (2012) Juris J. Meier Nature Reviews Endocrinology
- One-year treatment with exenatide vs. Insulin Glargine: Effects on postprandial glycemia, lipid profiles, and oxidative stress
- (2010) Mathijs C. Bunck et al. ATHEROSCLEROSIS
- Risk of Cardiovascular Disease Events in Patients With Type 2 Diabetes Prescribed the Glucagon-Like Peptide 1 (GLP-1) Receptor Agonist Exenatide Twice Daily or Other Glucose-Lowering Therapies: A retrospective analysis of the LifeLink database
- (2010) J. H. Best et al. DIABETES CARE
- Insulin use and increased risk of mortality in type 2 diabetes: a cohort study
- (2009) J.-M. Gamble et al. DIABETES OBESITY & METABOLISM
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started